Carlos J. ChaccourN. Regina RabinovichHannah SlaterSara E. CanavatiTeun BousemaMarcus LacerdaFeiko Ter KuileChris DrakeleyQuique BassatBrian D. FoyKevin KobylinskiUniversidad de NavarraInstituto de Salud Global de BarcelonaHarvard School of Public HealthImperial College LondonMahidol UniversityRadboud University Nijmegen Medical CentreFundação de Medicina Tropical Dr. Heitor Vieira DouradoLiverpool School of Tropical MedicineLondon School of Hygiene & Tropical MedicineCentro de Investigação em Saúde de Manhiça (CISM)Colorado State UniversityArmed Forces Research Institute of Medical Sciences, ThailandWalter Reed Institute of Research2018-11-232018-11-232015-06-11Malaria Journal. Vol.14, No.1 (2015)147528752-s2.0-84934981663https://repository.li.mahidol.ac.th/handle/20.500.14594/36100© 2015 Chaccour et al. The potential use of ivermectin as an additional vector control tool is receiving increased attention from the malaria elimination community, driven by the increased importance of outdoor/residual malaria transmission and the threat of insecticide resistance where vector tools have been scaled-up. This report summarizes the emerging evidence presented at a side meeting on "Ivermectin for malaria elimination: current status and future directions" at the annual meeting of the American Society of Tropical Medicine and Hygiene in New Orleans on November 4, 2014. One outcome was the creation of the "Ivermectin Research for Malaria Elimination Network" whose main goal is to establish a common research agenda to generate the evidence base on whether ivermectin-based strategies should be added to the emerging arsenal to interrupt malaria transmission.Mahidol UniversityImmunology and MicrobiologyMedicineArticleSCOPUS10.1186/s12936-015-0691-6